申请人:Hoechst Aktiengesellschaft
公开号:US04857520A1
公开(公告)日:1989-08-15
The invention relates to compounds of the formula I ##STR1## in which m denotes 1 or 2 and n denotes, 0, 1 or 2; R.sup.1 and R.sup.2 denote identical or different radicals from the series comprising hydrogen, optionally substituted alkyl, alkenyl, cycloalkyl, cycloalkenyl, cycloalkylalkyl, partly hydrogenated aryl and optionally substituted aralkyl; R.sup.3 and R.sup.4 denote identical or different radicals from the series comprising hydrogen, alkyl, alkenyl and optionally substituted aralkyl; Y denotes hydrogen or hydroxyl and Z denotes hydrogen, or Y and Z together denote oxo, and X denotes optionally substituted alkyl, alkenyl, cycloalkyl, optionally substituted 4-piperidinyl, optionally substituted aryl or indolyl, processes for their preparation, medicaments containing these compounds and their use, and to intermediates in their preparation.
本发明涉及式I的化合物##STR1## 其中m表示1或2,n表示0、1或2;R1和R2表示氢、可选取代的烷基、烯基、环烷基、环烯基、环烷基烷基、部分氢化芳基和可选取代的芳基烷基,R3和R4表示相同或不同的氢、烷基、烯基和可选取代的芳基烷基;Y表示氢或羟基,Z表示氢,或Y和Z一起表示氧代,X表示可选取代的烷基、烯基、环烷基、可选取代的4-哌啶基、可选取代的芳基或吲哚基。本发明还涉及制备这些化合物的方法、含有这些化合物的药物以及它们的应用,以及它们制备的中间体。